More T Cells versus Better T Cells in Patients with Breast Cancer
- PMID: 28974529
- DOI: 10.1158/2159-8290.CD-17-0858
More T Cells versus Better T Cells in Patients with Breast Cancer
Abstract
<b/> Characterization of intratumoral leukocyte populations may help in estimating patients' prognosis and predictions. A new study shows remarkable differences between the in situ and invasive breast cancer stages and highlights that cell number analyses should be complemented with characterization of T-cell functions, increasing the likelihood that immune competent antitumor T cells and further biomarkers are identified for guiding therapy choices. Cancer Discov; 7(10); 1062-4. ©2017 AACR.See related article by Gil Del Alcazar et al., p. 1098.
©2017 American Association for Cancer Research.
Comment on
-
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.Cancer Discov. 2017 Oct;7(10):1098-1115. doi: 10.1158/2159-8290.CD-17-0222. Epub 2017 Jun 26. Cancer Discov. 2017. PMID: 28652380 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
